Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease - PubMed (original) (raw)

. 2004 Apr;10(4):396-401.

doi: 10.1038/nm1023. Epub 2004 Mar 21.

Affiliations

• PMID: 15034573
• DOI: 10.1038/nm1023

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

Edith Passage et al. Nat Med. 2004 Apr.

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common hereditary peripheral neuropathy, affecting 1 in 2,500 people. The only treatment currently available is rehabilitation or corrective surgery. The most frequent form of the disease, CMT-1A, involves abnormal myelination of the peripheral nerves. Here we used a mouse model of CMT-1A to test the ability of ascorbic acid, a known promoter of myelination, to correct the CMT-1A phenotype. Ascorbic acid treatment resulted in substantial amelioration of the CMT-1A phenotype, and reduced the expression of PMP22 to a level below what is necessary to induce the disease phenotype. As ascorbic acid has already been approved by the FDA for other clinical indications, it offers an immediate therapeutic possibility for patients with the disease.

PubMed Disclaimer

Similar articles

• Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
  Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Sereda MW, et al. Nat Med. 2003 Dec;9(12):1533-7. doi: 10.1038/nm957. Epub 2003 Nov 9. Nat Med. 2003. PMID: 14608378
• A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
  Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Hörste G, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW. Fledrich R, et al. Brain. 2012 Jan;135(Pt 1):72-87. doi: 10.1093/brain/awr322. Epub 2011 Dec 20. Brain. 2012. PMID: 22189569
• Ascorbic acid inhibits PMP22 expression by reducing cAMP levels.
  Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontés M. Kaya F, et al. Neuromuscul Disord. 2007 Mar;17(3):248-53. doi: 10.1016/j.nmd.2006.12.008. Epub 2007 Feb 15. Neuromuscul Disord. 2007. PMID: 17303424
• [Charcot-Marie-Tooth disease].
  Lee YC, Chang MH, Lin KP. Lee YC, et al. Acta Neurol Taiwan. 2008 Sep;17(3):203-13. Acta Neurol Taiwan. 2008. PMID: 18975529 Review. Chinese.
• [Pathophysiology and new treatment for hereditary neuropathy].
  Nodera H, Kaji R. Nodera H, et al. No To Shinkei. 2004 Sep;56(9):761-70. No To Shinkei. 2004. PMID: 15552865 Review. Japanese. No abstract available.

Cited by

• Current Treatment Methods for Charcot-Marie-Tooth Diseases.
  Dong H, Qin B, Zhang H, Lei L, Wu S. Dong H, et al. Biomolecules. 2024 Sep 9;14(9):1138. doi: 10.3390/biom14091138. Biomolecules. 2024. PMID: 39334903 Free PMC article. Review.
• Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.
  Van Lent J, Prior R, Pérez Siles G, Cutrupi AN, Kennerson ML, Vangansewinkel T, Wolfs E, Mukherjee-Clavin B, Nevin Z, Judge L, Conklin B, Tyynismaa H, Clark AJ, Bennett DL, Van Den Bosch L, Saporta M, Timmerman V. Van Lent J, et al. Exp Mol Med. 2024 Jun;56(6):1348-1364. doi: 10.1038/s12276-024-01250-x. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825644 Free PMC article. Review.
• Neuron-Schwann cell interactions in peripheral nervous system homeostasis, disease, and preclinical treatment.
  Oliveira JT, Yanick C, Wein N, Gomez Limia CE. Oliveira JT, et al. Front Cell Neurosci. 2023 Oct 12;17:1248922. doi: 10.3389/fncel.2023.1248922. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37900588 Free PMC article. Review.
• The Current State of Charcot-Marie-Tooth Disease Treatment.
  Okamoto Y, Takashima H. Okamoto Y, et al. Genes (Basel). 2023 Jul 1;14(7):1391. doi: 10.3390/genes14071391. Genes (Basel). 2023. PMID: 37510296 Free PMC article. Review.
• Implantable Electroceutical Approach Improves Myelination by Restoring Membrane Integrity in a Mouse Model of Peripheral Demyelinating Neuropathy.
  Intisar A, Shin HY, Kim WH, Kang HG, Kim MY, Kim YS, Cho Y, Mo YJ, Lim H, Lee S, Lu QR, Lee YI, Kim MS. Intisar A, et al. Adv Sci (Weinh). 2022 Nov;9(32):e2201358. doi: 10.1002/advs.202201358. Epub 2022 Aug 17. Adv Sci (Weinh). 2022. PMID: 35975427 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program